Safety profile of Sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes - an analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial

被引：0
|
作者：
Maggioni, Aldo
Caterson, Ian
Coutinho, Walmir
Finer, Nick
Van Gaal, Luc
Sharma, Arya
Pedersen, Christian
James, W. Philip
机构：
[1] ANMCO Res Ctr, Florence, Italy
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Catholic Univ, Rio De Janeiro, Brazil
[4] Univ Cambridge, Wellcome Trust Clin Res Facility, Cambridge CB2 1TN, England
[5] Univ Hosp, Antwerp, Belgium
[6] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[7] Bispebjerg Hosp, Copenhagen, Denmark
[8] London Sch Hyg & Trop Med, London WC1, England
来源：
INTERNATIONAL JOURNAL OF OBESITY | 2007年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S167 / S167
页数：1
相关论文
共 50 条
  • [1] Tolerability of Sibutramine During a 6-week Treatment Period in High-Risk Patients With Cardiovascular Disease and/or Diabetes: A Preliminary Analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial
    Maggioni, Aldo P.
    Caterson, Ian
    Coutinho, Walmir
    Finer, Nick
    Van Gaal, Luc
    Sharma, Arya M.
    Torp-Pedersen, Christian
    Bacher, Peter
    Shepherd, Gillian
    Sun, Rui
    James, Philip
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 52 (05) : 393 - 402
  • [2] Clinically relevant weight loss achieved in high-risk patients during 6-week sibutramine treatment - an analysis from the sibutramine cardiovascular outcomes (SCOUT) trial
    Finer, Nick
    Caterson, Ian
    Coutinho, Walmir
    Van Gaal, Luc
    Maggioni, Aldo
    Sharma, Arya
    Torp-Pedersen, Christian
    James, W. Philip T.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S29 - S29
  • [3] Six-week treatment period with sibutramine reduces blood pressure in high-risk hypertensive patients - An analysis of the sibutramine cardiovascular outcomes ( SCOUT) trial
    Sharma, Arya M.
    Caterson, Ian
    Coutinho, Walmir
    Finer, Nick
    Van Gaal, Luc
    Maggioni, Aldo P.
    Torp-Pedersen, Christian
    James, W. Philip T.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (09) : 1490 - 1490
  • [4] Six-week treatment period with sibutramine reduces blood pressure in high-risk hypertensive patients - An analysis of the sibutramine cardiovascular outcomes (SCOUT) trial
    Sharma, Arya
    Caterson, Ian
    Coutinho, Walmir
    Finer, Nick
    Van Gaal, Luc
    Maggioni, Aldo
    Torp-Pedersen, Christian
    James, W. Philip T.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 : S168 - S168
  • [5] Does the risk profile of patients with cardiovascular disease and/or diabetes modify initial response to treatment with sibutramine? A preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial
    Caterson, I
    Sharma, A. M.
    Coutinho, W.
    Finer, N.
    Van Gaal, L.
    Maggioni, A.
    Torp-Pedersen, C.
    James, W. P. T.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 : S100 - S100
  • [6] Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT)
    Sharma, A. M.
    Caterson, I. D.
    Coutinho, W.
    Finer, N.
    Van Gaal, L.
    Maggioni, A. P.
    Torp-Pedersen, C.
    Bacher, H. P.
    Shepherd, G. M.
    James, W. P. T.
    DIABETES OBESITY & METABOLISM, 2009, 11 (03): : 239 - 250
  • [7] Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial
    Van Gaal, L. F.
    Caterson, I. D.
    Coutinho, W.
    Finer, N.
    Maggioni, A. P.
    Sharma, A. M.
    Torp-Pedersen, C.
    Ge, H.
    Moran, S. A.
    Shepherd, G. M.
    James, W. P. T.
    DIABETES OBESITY & METABOLISM, 2010, 12 (01): : 26 - 34
  • [8] Initial blood pressure response of high-risk patients with diabetes plus cardioavascular disease after 6-weeks Sibutramine treatment - an analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial
    Caterson, I.
    Coutinho, L.
    Finer, N.
    Van Gaal, L.
    Maggioni, A. P.
    Sharma, A. M.
    Torp-Pedersen, C.
    James, W. P. T.
    DIABETOLOGIA, 2007, 50 : S346 - S346
  • [9] Six-week treatment with sibutramine in hypertensive obese/overweight patients with high cardiovascular risk reduces blood pressure-an analysis of the sibutramine cardiovascular outcomes (SCOUT) trial
    Torp-Pedersen, C.
    Caterson, I.
    Coutinho, W.
    Finer, N.
    Van Gaal, L.
    Maggioni, A.
    Sharma, A. M.
    James, W. P. T.
    EUROPEAN HEART JOURNAL, 2007, 28 : 870 - 870
  • [10] SCOUT Trial Reports on the Safety Profile of Sibutramine in Patients with Cardiovascular Diseases
    Maggioni, Aldo P.
    PHYSICIAN AND SPORTSMEDICINE, 2009, 37 (03): : 95 - 97
12345